US2022089748A1PendingUtilityA1

Pdgf receptor beta binding polypeptides

Assignee: X BODY INCPriority: Dec 5, 2011Filed: Aug 24, 2021Published: Mar 24, 2022
Est. expiryDec 5, 2031(~5.4 yrs left)· nominal 20-yr term from priority
A61K 39/00C07K 2317/92C07K 14/71C12N 15/1093C07K 2317/94C07K 16/28C07K 2317/76C07K 14/49C12P 21/005C07K 16/2863C07K 2317/622C07K 2317/565C07K 16/22A61P 35/00A61K 2039/505A61P 43/00A61P 27/02
73
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides binding polypeptides (e.g., antibodies or fragments thereof) that specifically bind to a target antigen (e.g., a human antigen, e.g., human PDGFRβ) with high affinity. The invention also provides, libraries of binding polypeptides, pharmaceutical compositions, as well as nucleic acids encoding binding polypeptides, recombinant expression vectors and host cells for making such binding polypeptides. Methods of using binding polypeptide of the invention to diagnose and treat disease are also encompassed by the invention.

Claims

exact text as granted — not AI-modified
1 .- 39 . (canceled) 
     
     
         40 . A diverse library of unpaired VH domains, wherein each member of the library binds to human PDGFRβ, and wherein the library is a nucleic acid display library. 
     
     
         41 . The library of  claim 40 , wherein the nucleic acid display library is a DNA display library. 
     
     
         42 . The library of  claim 40 , wherein diversity lies in the FR1-FR3 regions, and wherein each member of the library comprises the CDR3 amino acid sequence set forth in SEQ ID NO: 1. 
     
     
         43 . A diverse library of stable VH/VL pairs, wherein each member of the library binds to human PDGFRβ, and wherein the library is a nucleic acid display library. 
     
     
         44 . The library of  claim 43 , wherein the nucleic acid display library is a DNA display library. 
     
     
         45 . The library of  claim 43 , wherein each member of the library comprises a VH domain comprising the CDR3 amino acid sequence set forth in SEQ ID NO: 1. 
     
     
         46 . The library of  claim 45 , wherein the VL domains are human VL domains.

Join the waitlist — get patent alerts

Track US2022089748A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.